Enzymotec Expands Activities in China

22 Mar 2012 --- Global biotech company commences operations in Shanghai - Local and regional customers to benefit.

--- Enzymotec, a dynamic, biotech company and a leading global supplier of lipid-based products, announced the opening of its Shanghai office.

The new branch of Enzymotec is aimed at supporting the company's growing business activities in China as well as providing its existing customers with expert, on-hand customer service.

With a foothold in over 40 countries, Enzymotec develops and manufactures lipid-based biofunctional and nutraceutical ingredients and end products that are based on sophisticated proprietary technologies.

"This is a significant step forward for Enzymotec, which has successfully expanded its commercial activities over the last few years," says Dr. Ariel Katz, CEO of Enzymotec.  "South East Asia in general and China in particular have become key markets for us due to the economic developments in the region. In addition, we believe that maintaining a local presence is highly important and fits our global marketing strategy."

Enzymotec's innovative solutions are divided into three business segments: 

  • Infant Nutrition Division  –  Producer of InFatTM, a clinically-proven ingredient in infant formulas that mimics the fat of human milk. InFatTM is marketed through Advanced Lipids AB, a joint venture of AAK and Enzymotec. Advanced Lipids is a primary supplier of fat ingredients for leading infant formulas in China. 
  • Bioactive Division  –  A major provider of lipid-based products providing high quality solutions for the body and mind. 
  • VAYA Pharma – A researched-based, specialty pharmaceutical division dedicated to the discovery, development, manufacturing and marketing of innovative and effective, clinically tested and safe natural lipid-based medicines.

 

To contact our editorial team please email us at editorial@cnsmedia.com

Enzymotec

Collapse

Who We Are

Enzymotec develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Since its establishment in 1998, the company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products. Our two business segments leverage our lipid-related expertise: Nutrition and Pharma.

Enzymotec's diverse range of products span the entire human life-cycle - from infancy to old age, providing key ingredients for use in infant formula and nutritional supplements, as well as branded medical foods.

Enzymotec's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track-record in turning advanced lipid science into commercially attractive, nutritional solutions, constantly enriching our unique cluster of technology and expertise.

What We Do

We develop clinically-validated products including bio-functional, lipid-based compounds that address a wide spectrum of growing consumer demands, such as optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases.

The comprehensive solutions we develop and manufacture are sold to major consumer companies through our global sales and marketing infrastructure.

How We Do It

We employ proprietary technologies to modify lipids harvested from natural sources, transforming these raw materials into unique and clinically-proven lipid based products. These products are familiar to the human body and possess beneficial secondary characteristics, such as extended shelf life and improved scent or taste profile.

Our Source of Competitive Advantage:

• Safe and clinically-proven products supported by proprietary technology and R&D expertise.

• Experienced leadership and scientific advisory boards.

• Diversified business model

• Strong customer relationships and partnerships

• Integrated scalable platform and product offering, based on state-of-the-art production capabilities.

Related Articles

Food Ingredients News

Food loss challenge: Rabobank’s start-up shortlist to help reduce food loss in Asia

15 Oct 2018 --- Rabobank is tackling the issue of food loss throughout the supply chain by focusing on holistic solutions and is running a competition where start-ups pitch their ideas to reduce food loss to food and agri industry leaders and investors. Through the Food Loss Challenge Asia, Rabobank aims to look for solutions to curb food loss from farm to market and is asking start-ups “Do you have an existing tech-based solution that reduces food loss from farm to market in Asia?”

Food Ingredients News

Danone to use Nutri-Score labels on fresh dairy products in Belgium

15 Oct 2018 --- Danone is to pioneer a color-coded food labeling system on all its fresh dairy products in Belgium. The French multinational food-products corporation is getting ahead of a government-backed voluntary scheme for food products which sees the Belgium health ministry encouraging better nutritional labeling. The Nutri-Score systems come at the time when consumers are paying much more attention to what they eat and is in line with Innova Markets Insights' top trend for 2018 – “Mindful Choices” – the increasingly thoughtful consumer continues to catalyze changes in the way that companies produce, package and label their products.

Food Ingredients News

Greencore sells US operations to Hearthside in US$1bn plus deal

15 Oct 2018 --- Greencore Group plc has agreed to the sale of its entire US business, Greencore US, to an affiliate of Hearthside Food Solutions LLC for US$1,075 million on a cash and debt-free basis. Greencore says that following the deal, it expects to have a leading position in its core UK market, greater financial and strategic flexibility and potential for dynamic capital management. Hearthside believes the transaction marks a significant step in the further growth and development of its network.

Food Ingredients News

Chr. Hansen acquires dairy ingredient supplier Hundsbichler, raises organic growth targets

15 Oct 2018 --- Chr. Hansen is further expanding its enzyme production and presence into the traditional segments of specialty cheeses, with the newly announced acquisition of the assets of Austrian-based ingredient supplier Österreichische Laberzeugung Hundsbichler GmbH. Hundsbichler products are widely recognized for high quality and the purchase will enable Chr. Hansen to offer cheesemakers a second-to-none product portfolio in the animal rennet space, according to the company. Separately, the company announced that it had achieved all the overall financial targets set at the beginning of the year and raised its ambitions 9-11 percent organic growth for next year.

Food Ingredients News

Start-up focus: US-based Variety Fun targets healthy and convenient snacks market, direct to your door

15 Oct 2018 --- Two entrepreneurs have turned their US$165,000 investment into a millennial-favorite snack subscription box, that is now projecting US$12 million dollars in sales for 2018 and over 500,000 boxes sold on Amazon. According to the company, Variety Fun’s subscription service delivers an assortment of snacks to US offices, improving workplace culture and boosting employee morale. Variety Fun is a snack subscription box that curates “hundreds of the best-tasting, classic and nutritional brands,” including Popcorners, Hippeas, and Popchips, for offices in the US. By partnering with over 500 snack brands, the company offers businesses the most affordable and convenient subscription snack service with the most extensive selection.

More Articles